Table 3.
Genotype ROP16 according to amino acid residue of position 503 and full-length alignment genotyping of GRA3
| Strain ID | ToxoDB genotype# | ROP16a | GRA3 | Virulence | References |
|---|---|---|---|---|---|
| GT1 | 10 | I/III | I | Vir | [40] |
| Me49 | 1 | II | II | Int | [40] |
| VEG | 2 | I/III | III | Non | [40] |
| Wh2 | 9 | I/III | μ-1 | Vir | [13] |
| Wh3 | 9 | I/III | μ-1 | Vir | [13] |
| Wh4 | 9 | I/III | μ-1 | Int | [13] |
| Wh5 | 9 | I/III | μ-1 | Vir | [13] |
| Wh6 | 9 | I/III | II | Non | [10] |
| Wh7 | 9 | I/III | μ-1 | Vir | [13] |
| Wh10 | 9 | I/III | μ-1 | Vir | This study |
| Wh12 | 9 | I/III | μ-1 | Vir | [12] |
| Wh13 | 9 | I/III | μ-1 | Vir | This study |
| Wh14 | 9 | I/III | μ-1 | Vir | [12] |
| Xz34 | 9 | I/III | μ-1 | Vir | This study |
| Xz38 | 9 | I/III | μ-1 | Vir | This study |
| Xz7 | 205 | I/III | I | Vir | This study |
| Xz8 | 205 | I/III | II | Vir | [12] |
| Xz9 | 205 | II | μ-2 | Vir | This study |
| Xz37 | 205 | II | μ-2 | Vir | This study |
| Xz39 | 205 | II | μ-2 | Vir | This study |
| Xz40 | 205 | II | μ-2 | Vir | This study |
| Gy5 | 9 | I/III | μ-1 | Vir | [11] |
Abbreviations: Int, intermediate virulence: Non, avirulence; Vir, virulence
aROP16I/III: identified by sequencing, indicating the amino acid residue of ROP16 at position 503 is leucine (seen in type I or type III strain) instead of serine (seen in type II strain). ROP16I/III is widely used since it more precise